36510132|t|LOTUS suppresses amyloid beta-induced dendritic spine elimination through the blockade of amyloid beta binding to PirB.
36510132|a|BACKGROUND: Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide but has no effective treatment. Amyloid beta (Abeta) protein, a primary risk factor for AD, accumulates and aggregates in the brain of patients with AD. Paired immunoglobulin-like receptor B (PirB) has been identified as a receptor of Abeta and Abeta-PirB molecular interactions that cause synapse elimination and synaptic dysfunction. PirB deletion has been shown to suppress Abeta-induced synaptic dysfunction and behavioral deficits in AD model mice, implying that PirB mediates Abeta-induced AD pathology. Therefore, inhibiting the Abeta-PirB molecular interaction could be a successful approach for combating AD pathology. We previously showed that lateral olfactory tract usher substance (LOTUS) is an endogenous antagonist of type1 Nogo receptor and PirB and that LOTUS overexpression promotes neuronal regeneration following damage to the central nervous system, including spinal cord injury and ischemic stroke. Therefore, in this study, we investigated whether LOTUS inhibits Abeta-PirB interaction and Abeta-induced dendritic spine elimination. METHODS: The inhibitory role of LOTUS against Abeta-PirB (or leukocyte immunoglobulin-like receptor subfamily B member 2: LilrB2) binding was assessed using a ligand-receptor binding assay in Cos7 cells overexpressing PirB and/or LOTUS. We assessed whether LOTUS inhibits Abeta-induced intracellular alterations and synaptotoxicity using immunoblots and spine imaging in a primary cultured hippocampal neuron. RESULTS: We found that LOTUS inhibits the binding of Abeta to PirB overexpressed in Cos7 cells. In addition, we found that Abeta-induced dephosphorylation of cofilin and Abeta-induced decrease in post-synaptic density-95 expression were suppressed in cultured hippocampal neurons from LOTUS-overexpressing transgenic (LOTUS-tg) mice compared with that in wild-type mice. Moreover, primary cultured hippocampal neurons from LOTUS-tg mice improved the Abeta-induced decrease in dendritic spine density. Finally, we studied whether human LOTUS protein inhibits Abeta binding to LilrB2, a human homolog of PirB, and found that human LOTUS inhibited the binding of Abeta to LilrB2 in a similar manner. CONCLUSIONS: This study implied that LOTUS improved Abeta-induced synapse elimination by suppressing Abeta-PirB interaction in rodents and inhibited Abeta-LilrB2 interaction in humans. Our findings revealed that LOTUS may be a promising therapeutic agent in counteracting Abeta-induced AD pathologies.
36510132	17	29	amyloid beta	Gene	351
36510132	90	102	amyloid beta	Gene	351
36510132	114	118	PirB	Gene	11025
36510132	132	151	Alzheimer's disease	Disease	MESH:D000544
36510132	153	155	AD	Disease	MESH:D000544
36510132	176	201	neurodegenerative disease	Disease	MESH:D019636
36510132	244	256	Amyloid beta	Gene	351
36510132	258	263	Abeta	Gene	351
36510132	300	302	AD	Disease	MESH:D000544
36510132	347	355	patients	Species	9606
36510132	361	363	AD	Disease	MESH:D000544
36510132	365	402	Paired immunoglobulin-like receptor B	Gene	11025
36510132	404	408	PirB	Gene	11025
36510132	447	452	Abeta	Gene	351
36510132	457	462	Abeta	Gene	351
36510132	463	467	PirB	Gene	11025
36510132	526	546	synaptic dysfunction	Disease	MESH:C536122
36510132	548	552	PirB	Gene	18733
36510132	589	594	Abeta	Gene	11820
36510132	603	623	synaptic dysfunction	Disease	MESH:C536122
36510132	628	647	behavioral deficits	Disease	MESH:D019958
36510132	651	653	AD	Disease	MESH:D000544
36510132	660	664	mice	Species	10090
36510132	680	684	PirB	Gene	11025
36510132	694	699	Abeta	Gene	351
36510132	708	710	AD	Disease	MESH:D000544
36510132	748	753	Abeta	Gene	351
36510132	754	758	PirB	Gene	11025
36510132	826	828	AD	Disease	MESH:D000544
36510132	969	973	PirB	Gene	18733
36510132	1045	1081	damage to the central nervous system	Disease	MESH:D002493
36510132	1093	1111	spinal cord injury	Disease	MESH:D013119
36510132	1116	1131	ischemic stroke	Disease	MESH:D002544
36510132	1198	1203	Abeta	Gene	351
36510132	1204	1208	PirB	Gene	11025
36510132	1225	1230	Abeta	Gene	351
36510132	1314	1319	Abeta	Gene	351
36510132	1320	1324	PirB	Gene	11025
36510132	1390	1396	LilrB2	Gene	10288
36510132	1460	1464	Cos7	CellLine	CVCL:0224
36510132	1486	1490	PirB	Gene	11025
36510132	1540	1545	Abeta	Gene	351
36510132	1584	1599	synaptotoxicity	Disease	
36510132	1731	1736	Abeta	Gene	351
36510132	1740	1744	PirB	Gene	11025
36510132	1762	1766	Cos7	CellLine	CVCL:0224
36510132	1801	1806	Abeta	Gene	11820
36510132	1848	1853	Abeta	Gene	11820
36510132	2006	2010	mice	Species	10090
36510132	2043	2047	mice	Species	10090
36510132	2110	2114	mice	Species	10090
36510132	2128	2133	Abeta	Gene	351
36510132	2207	2212	human	Species	9606
36510132	2236	2241	Abeta	Gene	351
36510132	2253	2259	LilrB2	Gene	10288
36510132	2263	2268	human	Species	9606
36510132	2280	2284	PirB	Gene	11025
36510132	2301	2306	human	Species	9606
36510132	2338	2343	Abeta	Gene	351
36510132	2347	2353	LilrB2	Gene	10288
36510132	2427	2432	Abeta	Gene	351
36510132	2476	2481	Abeta	Gene	351
36510132	2482	2486	PirB	Gene	11025
36510132	2524	2529	Abeta	Gene	351
36510132	2530	2536	LilrB2	Gene	10288
36510132	2552	2558	humans	Species	9606
36510132	2647	2652	Abeta	Gene	351
36510132	2661	2663	AD	Disease	MESH:D000544
36510132	Association	MESH:C536122	11025
36510132	Association	MESH:D000544	11025
36510132	Association	MESH:D019958	18733
36510132	Association	MESH:C536122	351
36510132	Association	MESH:D000544	351
36510132	Association	MESH:C536122	18733
36510132	Bind	11025	351
36510132	Positive_Correlation	MESH:C536122	11820

